About Epicrispr Biotechnologies
Epicrispr Biotechnologies is a private company based in South San Francisco, California. It has reported $176,754,406 raised in one offering on Form D since August 2026. Its chief executive is Amber Salzman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 4, 2018 | Aug 26, 2026 | $176,754,406of $212.7M target | 47 | $3.7M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Epicrispr Biotechnologies's Form D filed Aug 26, 2026.
LQ
Lei Qi
Scientific Founder and director
EC
AL
Anran Li
Director
HZ
Haorui Zhang
Executive officer and director
JK
Jennifer King
Director
AL
Andrew Lam
Director
